{
    "2019-02-25": [
        [
            {
                "time": "",
                "original_text": "首个国产生物类似药利妥昔单抗获批上市 复星医药：该新药尚需取得GMP认证证书",
                "features": {
                    "keywords": [
                        "国产",
                        "生物类似药",
                        "利妥昔单抗",
                        "复星医药",
                        "GMP认证"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)附属非霍奇金淋巴瘤治疗药物上市注册申请获批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "非霍奇金淋巴瘤",
                        "治疗药物",
                        "上市注册申请"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国家药监局：首个国产生物类似药利妥昔单抗获批上市",
                "features": {
                    "keywords": [
                        "国家药监局",
                        "国产",
                        "生物类似药",
                        "利妥昔单抗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "政策“脱敏”与创新药的长期空间",
                "features": {
                    "keywords": [
                        "政策",
                        "脱敏",
                        "创新药",
                        "长期空间"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2019年最新创投概念龙头股有哪些？2019年创投概念龙头股一览",
                "features": {
                    "keywords": [
                        "2019年",
                        "创投概念",
                        "龙头股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "创投"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "石药集团遭大华继显唱淡 现逆势跌逾2%",
                "features": {
                    "keywords": [
                        "石药集团",
                        "大华继显",
                        "唱淡",
                        "逆势跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}